Journal of Bone and Mineral Research · 2007 · 55 citations · 40 references
MedicineCell BiologyApoptosisBone MetabolismOncogenesBcl-2 Family ProteinsBone DevelopmentBone FormationOsteoblast BiologyOsteoclast BiologyOsteogenesisAnti-apoptotic BalanceAnti-apoptotic ProteinsAnti-apoptotic RegulatorsApoptosis In Bone CellsBcl-2 Protein ExpressionBone Cell ApoptosisBone Marrow - Derived CellsRankl-mediated Osteoclastogenesis
INTRODUCTION: B-cell leukemia/lymphoma 2 (Bcl2) is a proto-oncogene best known for its ability to suppress cell death. However, the role of Bcl2 in the skeletal system is unknown. Bcl2 has been hypothesized to play an important anti-apoptotic role in osteoblasts during anabolic actions of PTH. Although rational, this has not been validated in vivo; hence, the impact of Bcl2 in bone remains unknown. MATERIALS AND METHODS: The bone phenotype of Bcl2 homozygous mutant (Bcl2(-/-)) mice was analyzed with histomorphometry and muCT. Calvarial osteoblasts were isolated and evaluated for their cellular activity. Osteoclastogenesis was induced from bone marrow cells using RANKL and macrophage-colony stimulating factor (M-CSF), and their differentiation was analyzed. PTH(1-34) (50 microg/kg) or vehicle was administered daily to Bcl2(+/+) and Bcl2(-/-) mice (4 days old) for 9 days to clarify the influence of Bcl2 ablation on PTH anabolic actions. Western blotting and real-time PCR were performed to detect Bcl2 expression in calvarial osteoblasts in response to PTH ex vivo. RESULTS: There were reduced numbers of osteoclasts in Bcl2(-/-) mice, with a resultant increase in bone mass. Bcl2(-/-) bone marrow-derived osteoclasts ex vivo were significantly larger in size and short-lived compared with wildtype, suggesting a pro-apoptotic nature of Bcl2(-/-) osteoclasts. In contrast, osteoblasts were entirely normal in their proliferation, differentiation, and mineralization. Intermittent administration of PTH increased bone mass similarly in Bcl2(+/+) and Bcl2(-/-) mice. Finally, Western blotting and real-time PCR showed that Bcl2 levels were not induced in response to PTH in calvarial osteoblasts. CONCLUSIONS: Bcl2 is critical in osteoclasts but not osteoblasts. Osteoclast suppression is at least in part responsible for increased bone mass of Bcl2(-/-) mice, and Bcl2 is dispensable in PTH anabolic actions during bone growth.
40
Osteoblastic cells regulate the haematopoietic stem cell niche
Laura M. Calvi, G. B. Adams, Kathryn Weibrecht et al. · Nature · 2003 · 3.4K citations
Life Sciences, Biology, Cell Biology +13
Involvement of the <i>bcl</i> -2 Gene in Human Follicular Lymphoma
Yoshihide Tsujimoto, Jeffrey Cossman, Elaine S. Jaffe et al. · Science · 1985 · 1.8K citations